title: Interleukin-6, interleukin-8, and interleukin-10 in kidney transplantation: improved risk strategy?
authors.affiliation: Surgical Research, Department of General Surgery, Muenster University Hospital, Muenster, Germany. diller@uni-muenster.de
authors.forename: R
authors.initials: R
authors.lastname: Diller
authors.forename: D
authors.initials: D
authors.lastname: Palmes
authors.forename: K-H
authors.initials: KH
authors.lastname: Dietl
authors.forename: N
authors.initials: N
authors.lastname: Senninger
authors.forename: G
authors.initials: G
authors.lastname: Winde
authors.forename: H-U
authors.initials: HU
authors.lastname: Spiegel
mesh_terms: D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016753:Interleukin-10 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D016209:Interleukin-8 / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D015166:Monitoring, Immunologic; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012016:Reference Values; D012044:Regression Analysis; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D015850:Interleukin-6; D016209:Interleukin-8; D016753:Interleukin-10